Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSQS2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,673
Award facts
- Contract value 100% obligated
- $25,673.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,673.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order was issued on January 13, 2026, with an ultimate completion date of February 4, 2026, and carries no set-aside designation, indicating the award was made through full and open competition. The product will be delivered to Park Ridge, Illinois, and will support the Department of Defense's pharmaceutical supply needs through DLA's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for military healthcare facilities worldwide. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue multiple delivery orders for a comprehensive range of pharmaceuticals and medical consumables. DMS Pharmaceutical Group's established track record of supplying specialized pharmaceutical products, including specialty surgical items such as EXPAREL, demonstrates its capability to fulfill the diverse medical supply requirements of the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FSQS2?
SPE2DR26FSQS2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FSQS2 worth?
The government has obligated $25,673 on SPE2DR26FSQS2.
Is contract SPE2DR26FSQS2 an order under another contract?
Yes. SPE2DR26FSQS2 is a delivery order under SPE2DR25D9348, an indefinite delivery contract.
Was contract SPE2DR26FSQS2 competed?
The extent of competition for SPE2DR26FSQS2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award